Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AroCell AB

AROC
Current price
0.42 SEK +0.02 SEK (+5.00%)
Last closed 0.41 SEK
ISIN SE0003883990
Sector Healthcare
Industry Diagnostics & Research
Exchange Stockholm Exchange
Capitalization 95 581 605 SEK
Yield for 12 month -8.30 %
1Y
3Y
5Y
10Y
15Y
AROC
21.11.2021 - 28.11.2021

AroCell AB (publ), a vitro diagnostics company, develops and markets blood and urine sample test products for use in the treatment of breast, prostate, and bladder cancers. The company provides AroCell TK 210 ELISA, an immunoassay kit for the determination of human Thymidine Kinase 1 protein concentration in blood samples; and UBC Rapid for diagnosing and monitoring bladder cancer patients. It also offers TUBEX TF, an in vitro diagnostic test for the detection of acute typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden. Address: KarlsbodavAegen 39, Stockholm, Sweden, 168 67

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.07 SEK

P/E ratio

Dividend Yield

Current Year

+42 927 341 SEK

Last Year

+36 890 042 SEK

Current Quarter

+13 959 695 SEK

Last Quarter

+15 233 375 SEK

Current Year

-2 096 549 SEK

Last Year

-2 099 535 SEK

Current Quarter

+3 071 015 SEK

Last Quarter

+2 767 796 SEK

Key Figures AROC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -5 990 420 SEK
Operating Margin TTM -72.39 %
PE Ratio
Return On Assets TTM -19.25 %
PEG Ratio
Return On Equity TTM -32.55 %
Wall Street Target Price 10.07 SEK
Revenue TTM 51 449 175 SEK
Book Value 0.56 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 30.80 %
Dividend Yield
Gross Profit TTM 6 455 209 SEK
Earnings per share -0.23 SEK
Diluted Eps TTM -0.23 SEK
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -98.04 %

Dividend Analytics AROC

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History AROC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AROC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.99
Price Sales TTM 1.86
Enterprise Value EBITDA -1.34
Price Book MRQ 0.74

Financials AROC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AROC

For 52 weeks

0.30 SEK 0.66 SEK
50 Day MA 0.42 SEK
Shares Short Prior Month
200 Day MA 0.46 SEK
Short Ratio
Shares Short
Short Percent